Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Blood Glucose Test Strip Market Trends, Growth And Share Analysis By Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Forecast Till 2032


ID: MRFR/MED/0470-CR | 80 Pages | Author: Rahul Gotadki| February 2021
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF THE STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS

1.2.3 LIMITATIONS

1.3 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

2.4 MARKET SIZE ESTIMATION

2.5 FORECAST MODEL

3 FORECAST INDICATORS

3.1 GROWTH DRIVERS

3.1.1 CONVENIENCE OF SELF BLOOD GLUCOSE MONITORING OVER TRADITIONAL METHODS

3.1.2 TECHNOLOGICAL ADVANCEMENTS

3.1.3 RISING DIABETIC POPULATION

3.1.4 PLAYERS ENGAGED IN CREATINGAWARENESS REGARDING REGULAR BLOOD GLUCOSE MONITORING

3.1.5 GOVERNMENT INITIATIVES TO PROPEL AUSTRALIAN BLOOD GLUCOSE TEST STRIP MARKET

3.1.6 RISING DISPOSABLE INCOME OF EMERGING ECONOMIES

3.2 GROWTH BARRIERS

3.2.1 INADEQUATE REIMBURSEMENT FOR TEST STRIPS

3.2.2 LOW ADOPTION OF SMBG IN EMERGING ECONOMIES AS COMPARED TO DEVELOPED REGIONS

3.2.3 ADVENT OF GENERIC BLOOD GLUCOSE TEST STRIPS

3.3 OPPORTUNITIES

3.3.1 EMERGING ECONOMIES

4 GLOBAL BLOOD GLUCOSE TEST STRIP MARKET

5 BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6 BLOOD GLUCOSE TEST STRIP MARKET, BY REGION

6.1 NORTH AMERICA

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.2 EUROPE

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.3 ASIA-PACIFIC

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.4 LATIN AMERICA

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.5 MIDDLE EAST & AFRICA

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

7 COMPETITIVE LANDSCAPE

7.1 PRODUCTION CAPACITY

7.2 MARKET SHARE ANALYSIS

7.2.1 GLOBAL

7.2.2 NORTH AMERICA

7.2.3 EUROPE

7.2.4 ASIA-PACIFIC

7.2.5 LATIN AMERICA, MIDDLE EAST, AND AFRICA

7.3 COMPARATIVE ANALYSI

7.3.1 COMPARATIVE ANALYSIS: KEY PLAYERS

8 COMPANY PROFILES

8.1 ABBOTT LABORATORIES

8.1.1 BUSINESS OVERVIEW

8.1.2 FINANCIALS

8.1.3 PRODUCT PORTFOLIO

8.1.4 DEVELOPMENTS

8.2 ROCHE DIAGNOSTICS

8.2.1 BUSINESS OVERVIEW

8.2.2 FINANCIALS

8.2.3 PRODUCT PORTFOLIO

8.2.4 DEVELOPMENTS

8.3 LIFESCAN, INC. (A JOHNSON & JOHNSON COMPANY)

8.3.1 BUSINESS OVERVIEW

8.3.2 FINANCIALS (J&J)

8.3.3 PRODUCT PORTFOLIO

8.3.4 DEVELOPMENT

8.4 I-SENS, INC.

8.4.1 BUSINESS OVERVIEW

8.4.2 FINANCIALS

8.4.3 PRODUCT PORTFOLIO

8.4.4 DEVELOPMENT

8.5 TRIVIDIA HEALTH (PREVIOUSLY KNOWN AS NIPRO DIAGNOSTICS, INC.)

8.5.1 BUSINESS OVERVIEW

8.5.2 FINANCIALS

8.5.3 PRODUCT PORTFOLIO

8.5.4 DEVELOPMENTS

8.6 ASCENSIA DIABETES CARE HOLDINGS AG (PREVIOUSLY KNOWN AS BAYER DIABETES CARE)

8.6.1 BUSINESS OVERVIEW

8.6.2 FINANCIALS

8.6.3 PRODUCT PORTFOLIO

8.6.4 DEVELOPMENTS

8.7 APEX BIOTECHNOLOGY CORPORATION

8.7.1 BUSINESS OVERVIEW

8.7.2 FINANCIALS

8.7.3 PRODUCT PORTFOLIO

8.7.4 DEVELOPMENTS

8.8 AGAMATRIX INC

8.8.1 BUSINESS OVERVIEW

8.8.2 FINANCIALS

8.8.3 PRODUCT PORTFOLIO

8.8.4 DEVELOPMENTS

8.9 TAIDOC TECHNOLOGY CORPORATION

8.9.1 BUSINESS OVERVIEW

8.9.2 FINANCIALS

8.9.3 PRODUCT PORTFOLIO

8.9.4 DEVELOPMENTS

8.10 UNIVERSAL BIOSENSORS

8.10.1 BUSINESS OVERVIEW

8.10.2 FINANCIALS

8.10.3 PRODUCT PORTFOLIO

8.10.4 DEVELOPMENTS

8.11 BEIJING YICHENG ELECTRONIC CO., LTD.

8.11.1 BUSINESS OVERVIEW

8.11.2 FINANCIALS

8.11.3 PRODUCT PORTFOLIO

8.11.4 DEVELOPMENTS

8.12 SANNUO BIOSENSOR INC.

8.12.1 BUSINESS OVERVIEW

8.12.2 FINANCIALS

8.12.3 PRODUCT PORTFOLIO

8.12.4 DEVELOPMENTS

8.13 SHANGHAI MICROSENSE TM INC.

8.13.1 BUSINESS OVERVIEW

8.13.2 FINANCIALS

8.13.3 PRODUCT PORTFOLIO

8.13.4 DEVELOPMENTS

8.14 ACON LABORATORIES, INC.

8.14.1 BUSINESS OVERVIEW

8.14.2 FINANCIALS

8.14.3 PRODUCT PORTFOLIO

8.14.4 DEVELOPMENTS

8.15 ALLMEDICUS

8.15.1 BUSINESS OVERVIEW

8.15.2 FINANCIALS

8.15.3 PRODUCT PORTFOLIO

8.15.4 DEVELOPMENTS

8.16 NATIONAL DIAGNOSTIC PRODUCTS

8.16.1 BUSINESS OVERVIEW

8.16.2 FINANCIALS

8.16.3 PRODUCT PORTFOLIO

8.16.4 DEVELOPMENTS

8.17 HMD BIOMEDICAL

8.17.1 BUSINESS OVERVIEW

8.17.2 FINANCIALS

8.17.3 PRODUCT PORTFOLIO

8.17.4 DEVELOPMENTS

8.18 YUWELL-JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.

8.18.1 BUSINESS OVERVIEW

8.18.2 FINANCIALS

8.18.3 PRODUCT PORTFOLIO

8.18.4 DEVELOPMENTS

8.19 77 ELEKTRONIKA KFT.

8.19.1 BUSINESS OVERVIEW

8.19.2 FINANCIALS

8.19.3 PRODUCT PORTFOLIO

8.19.4 DEVELOPMENTS

8.20 B. BRAUN MELSUNGEN AG

8.20.1 BUSINESS OVERVIEW

8.20.2 FINANCIALS

8.20.3 PRODUCT PORTFOLIO

8.20.4 DEVELOPMENTS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.